Exchange Traded Concepts LLC Has $10.13 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Exchange Traded Concepts LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 7.8% during the third quarter, Holdings Channel reports. The fund owned 17,332 shares of the healthcare conglomerate’s stock after selling 1,474 shares during the quarter. Exchange Traded Concepts LLC’s holdings in UnitedHealth Group were worth $10,134,000 as of its most recent SEC filing.

A number of other institutional investors also recently modified their holdings of UNH. Carnegie Investment Counsel increased its stake in UnitedHealth Group by 2.7% during the 3rd quarter. Carnegie Investment Counsel now owns 26,556 shares of the healthcare conglomerate’s stock valued at $15,527,000 after purchasing an additional 707 shares in the last quarter. Annex Advisory Services LLC increased its stake in UnitedHealth Group by 2.7% during the 3rd quarter. Annex Advisory Services LLC now owns 41,955 shares of the healthcare conglomerate’s stock valued at $24,530,000 after purchasing an additional 1,110 shares in the last quarter. Brown Miller Wealth Management LLC increased its stake in UnitedHealth Group by 1.1% during the 3rd quarter. Brown Miller Wealth Management LLC now owns 6,136 shares of the healthcare conglomerate’s stock valued at $3,587,000 after purchasing an additional 64 shares in the last quarter. HCR Wealth Advisors increased its stake in UnitedHealth Group by 2.8% during the 3rd quarter. HCR Wealth Advisors now owns 2,265 shares of the healthcare conglomerate’s stock valued at $1,324,000 after purchasing an additional 61 shares in the last quarter. Finally, Ritholtz Wealth Management grew its stake in shares of UnitedHealth Group by 40.9% in the 3rd quarter. Ritholtz Wealth Management now owns 18,391 shares of the healthcare conglomerate’s stock worth $10,753,000 after acquiring an additional 5,339 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insiders Place Their Bets

In other news, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now directly owns 29,501 shares in the company, valued at approximately $16,812,029.88. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, EVP Erin Mcsweeney sold 1,500 shares of the stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total transaction of $868,545.00. Following the completion of the sale, the executive vice president now directly owns 7,785 shares in the company, valued at $4,507,748.55. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CAO Thomas E. Roos sold 2,851 shares of the stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares of the company’s stock, valued at $16,812,029.88. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

NYSE:UNH opened at $598.05 on Monday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.88 and a current ratio of 0.88. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $607.94. The firm has a market cap of $552.25 billion, a price-to-earnings ratio of 39.66, a PEG ratio of 1.66 and a beta of 0.58. The business’s fifty day moving average is $583.64 and its 200 day moving average is $531.35.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. The business had revenue of $98.86 billion for the quarter, compared to analyst estimates of $98.73 billion. UnitedHealth Group had a return on equity of 26.55% and a net margin of 3.66%. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the company earned $6.14 EPS. Research analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were paid a $2.10 dividend. The ex-dividend date of this dividend was Monday, September 16th. This represents a $8.40 dividend on an annualized basis and a yield of 1.40%. UnitedHealth Group’s dividend payout ratio is currently 55.70%.

Analysts Set New Price Targets

Several analysts have recently issued reports on UNH shares. Morgan Stanley upped their target price on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. KeyCorp started coverage on shares of UnitedHealth Group in a research note on Friday. They issued an “overweight” rating and a $675.00 target price for the company. StockNews.com lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, September 25th. HSBC boosted their price target on shares of UnitedHealth Group from $580.00 to $610.00 in a report on Thursday, July 18th. Finally, Wells Fargo & Company boosted their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Buy” and an average price target of $617.37.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.